EnteroBiotix's James McIlroy says EBX-102-02 could address treatment gaps in IBS, which impacts up to 10% of the global population.
The post EnteroBiotix nets $25m to progress microbiome-based IBS drug appeared first on Clinical Trials Arena.
تشهَد الجهود العالمية في مكافحة التهاب الكبد الفيروسي تقدمًا ملحوظًا خلال السنوات الماضية مع تراجع عدد الإصابات، فما الذي كشَفه تقرير منظمة الصحة؟
Thousands of patients will be offered a new injectable form of an immunotherapy drug that takes minutes.
Recent court decisions could mean tens of millions of taxpayers are owed, the Taxpayer Advocate Service warns.
Acting Attorney General Todd Blanche said Sunday that the indictment of former FBI Director James Comey did not solely result from an Instagram post depicting seashells …